Clinical Trial Update: Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation. [Phase 2]

View source ↗

Summary

A Phase 2 trial completed evaluating an antiemetic therapy to prevent nausea and vomiting in multiple myeloma patients undergoing stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Eisai Inc. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED